A clinical intake specialist will conduct an initial assessment to determine the appropriate level of care and discuss insurance verification, scheduling, and any questions about the treatment process
Furthermore, there is trend for differences between the effects of SGLt2i/GLP1 among those using metformin vs metformin-naive patients, with a trend towards larger benefit among those without metformin
GLP-1 therapy integrates well with: comprehensive longevity protocols (given the metabolic benefits beyond weight loss improved HbA1c, lipid profile, blood pressure, and inflammatory markers)
Currently, the Modified GRF (129) / Ipamorelin Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research